Yanqing Pang

483 total citations
15 papers, 431 citations indexed

About

Yanqing Pang is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Yanqing Pang has authored 15 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yanqing Pang's work include Synthesis and biological activity (7 papers), Cancer Treatment and Pharmacology (3 papers) and Organoselenium and organotellurium chemistry (3 papers). Yanqing Pang is often cited by papers focused on Synthesis and biological activity (7 papers), Cancer Treatment and Pharmacology (3 papers) and Organoselenium and organotellurium chemistry (3 papers). Yanqing Pang collaborates with scholars based in China, Germany and Hong Kong. Yanqing Pang's co-authors include Xingshu Li, Jun Yan, Ling Huang, Baijiao An, Jinhui Hu, Sheng Yin, Junsheng Zhang, Lanlan Lou, Jie Chen and Jianfei Sheng and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Yanqing Pang

15 papers receiving 425 citations

Peers

Yanqing Pang

TOXIC

PHARM

ONCOL

Christiane Scherer Germany

Arthur Y. Shaw United States

Omaima M. Abdelhafez Egypt

Melissa S. Bentle United States

Takuya Seko Japan

Manal M. Kandeel Egypt

Dina H. Dawood Egypt

Brian K. Adams United States

K. Hajela India

Robert M. Rzasa United States

Christiane Scherer Germany

Yanqing Pang

229 ×0.8

80 ×0.5

TOXIC

162 ×1.2

31 ×0.4

PHARM

39 ×0.9

ONCOL

Citations per year, relative to Yanqing Pang Yanqing Pang (= 1×) peers Christiane Scherer

Countries citing papers authored by Yanqing Pang

Since Specialization

Citations

This map shows the geographic impact of Yanqing Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqing Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqing Pang more than expected).

Fields of papers citing papers by Yanqing Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqing Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqing Pang. The network helps show where Yanqing Pang may publish in the future.

Co-authorship network of co-authors of Yanqing Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqing Pang. A scholar is included among the top collaborators of Yanqing Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqing Pang. Yanqing Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pang, Yanqing, et al.. (2025). A phase I, single-center, randomized, open-label, three-period crossover study to evaluate the drug–drug interaction between ZSP1273 and oseltamivir in healthy Chinese subjects. Antimicrobial Agents and Chemotherapy. 69(4). e0172924–e0172924. 2 indexed citations

Hu, Jinhui, Li Chen, Yunfei Hu, et al.. (2023). Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR. Molecules. 28(3). 1304–1304. 9 indexed citations

Li, Feng, et al.. (2023). 7-Dehydrocholesterol protects against circadian disruption and experimental colitis: potential role of RORα/γ. PubMed. 2(6). load034–load034. 2 indexed citations

Li, Yongchuan, et al.. (2023). Identification of acetylshikonin as a novel tubulin polymerization inhibitor with antitumor activity in human hepatocellular carcinoma cells. Journal of Gastrointestinal Oncology. 14(6). 2574–2586. 2 indexed citations

Zhou, Jingwei, et al.. (2022). Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis. Journal of Medicinal Chemistry. 65(6). 4687–4708. 24 indexed citations

Yan, Jun, Yanqing Pang, Qiaoxuan Zhang, et al.. (2019). Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1–Nrf2–ARE Pathway and Attenuates Aβ-Induced Cognitive Impairment in Vivo. ACS Chemical Neuroscience. 10(6). 2903–2914. 33 indexed citations

An, Baijiao, Tingting Pan, Jinhui Hu, et al.. (2019). The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer. European Journal of Medicinal Chemistry. 183. 111709–111709. 23 indexed citations

Pang, Yanqing, et al.. (2019). Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo. European Journal of Medicinal Chemistry. 182. 111670–111670. 27 indexed citations

Pang, Yanqing, Jun Yan, Baijiao An, Ling Huang, & Xingshu Li. (2017). The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry. 25(12). 3059–3067. 13 indexed citations

10.

Pang, Yanqing, Baijiao An, Lanlan Lou, et al.. (2017). Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents. Journal of Medicinal Chemistry. 60(17). 7300–7314. 139 indexed citations

11.

Yan, Jun, Yanqing Pang, Yali Wang, et al.. (2015). A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells. Biochemical Pharmacology. 97(1). 51–61. 31 indexed citations

12.

Chen, Jie, Jun Yan, Jinhui Hu, et al.. (2015). Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents. RSC Advances. 5(83). 68128–68135. 34 indexed citations

13.

Yan, Jun, Yanqing Pang, Jie Chen, et al.. (2015). Synthesis, biological evaluation and mechanism study of a class of cyclic combretastatin A-4 analogues as novel antitumour agents. RSC Advances. 5(119). 98527–98537. 14 indexed citations

14.

Hu, Jinhui, Jun Yan, Jie Chen, et al.. (2015). Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents. MedChemComm. 6(7). 1318–1327. 25 indexed citations

15.

Luo, Zonghua, Liang Liang, Jianfei Sheng, et al.. (2014). Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 22(4). 1355–1361. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact